BeOne Medicines (ONC) Change in Cash (2015 - 2026)

BeOne Medicines (ONC) has reported Change in Cash for 12 consecutive years, with $243.8 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Change in Cash rose 325.39% year-over-year to $243.8 million; the TTM figure through Mar 2026 stood at $2.3 billion (up 939.04% YoY), while the FY2025 annual figure was $2.0 billion, up 460.15% from the prior year.
• Change in Cash declined to $243.8 million in Q1 2026 per ONC's latest filing, from $499.1 million in the prior quarter.
• Across five years, Change in Cash topped out at $1.3 billion in Q3 2025 and bottomed at -$378.5 million in Q1 2024.
• Historically, Change in Cash has averaged $27.7 million across 5 years, with a median of -$74.7 million in 2024.
• Annual changes were most pronounced in 2023 — Change in Cash tumbled 1064.93% — and 2025, when it soared 1286.91%.
• BeOne Medicines' Change in Cash stood at -$325.5 million in 2022, then jumped by 132.29% to $105.1 million in 2023, then sank by 171.06% to -$74.7 million in 2024, then soared by 768.32% to $499.1 million in 2025, then plunged by 51.16% to $243.8 million in 2026.
• Business Quant data shows ONC's Change in Cash at $243.8 million in Q1 2026, $499.1 million in Q4 2025, and $1.3 billion in Q3 2025.